GE HealthCare Technologies Inc.
GEHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.54 | -1.26 | -0.74 | 0.23 |
| FCF Yield | 1.41% | 0.02% | 0.27% | 2.27% |
| EV / EBITDA | 45.44 | 46.83 | 46.43 | 38.91 |
| Quality | ||||
| ROIC | 1.67% | 1.90% | 2.08% | 2.82% |
| Gross Margin | 38.69% | 39.65% | 42.12% | 42.77% |
| Cash Conversion Ratio | 1.28 | 0.19 | 0.43 | 1.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.63% | 1.60% | 1.91% | 2.36% |
| Free Cash Flow Growth | 5,937.50% | -91.84% | -87.92% | 25.15% |
| Safety | ||||
| Net Debt / EBITDA | 7.47 | 8.10 | 7.15 | 5.98 |
| Interest Coverage | 5.88 | 5.79 | 5.67 | 7.22 |
| Efficiency | ||||
| Inventory Turnover | 1.37 | 1.32 | 1.28 | 1.57 |
| Cash Conversion Cycle | 62.42 | 59.85 | 49.60 | 42.02 |